Showing results (1-10 of 518) with videos related to
Sort By:
Pageof 52
Expert Review of Vaccines|January 9, 2004
Preventative and therapeutic vaccines for cervical cancerRichard Roden, T-C WuNature Reviews. Cancer|September 23, 2006
How will HPV vaccines affect cervical cancer?Richard Roden, T-C WuDiscovery Medicine|January 20, 2007
The impact of preventive HPV vaccinationRichard Roden, Archana Monie, T C WuBiologics : Targets & Therapy|August 27, 2009
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancerArchana Monie, Chien-Fu Hung, Richard Roden, et al.Immunological Reviews|March 28, 2008
Antigen-specific immunotherapy of cervical and ovarian cancerChien-Fu Hung, T C Wu, Archana Monie, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 7, 2013
Control of HPV infection and related cancer through vaccinationNam Phuong Tran, Chien-Fu Hung, Richard Roden, et al.American Journal of Obstetrics and Gynecology|April 9, 2008
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesisRobert J Kurman, Kala Visvanathan, Richard Roden, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.Vaccine|December 22, 2007
Generation and characterization of a preventive and therapeutic HPV DNA vaccineDaejin Kim, Ratish Gambhira, Balasubramanyam Karanam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinomaM Jim Yen, Chih-Yi Hsu, Tsui-Lien Mao, et al.Pageof 52